Related Experiment Video
Updated: Aug 10, 2026
06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Effect of chronically increased erythrocyte complement receptors on immune complex nephritis
L A Hebert1, D J Birmingham, J D Mahan
1Department of Internal Medicine, Ohio State University, Columbus.
Kidney International
|February 1, 1994
Summary
Increasing erythrocyte complement receptor Type 1 (E-CR1) levels may protect against immune complex-mediated glomerulonephritis (IC-GN). This study tested if chronically elevated E-CR1 prevents IC-GN in cynomolgus monkeys.
Area of Science:
- Immunology
- Nephrology
- Primate Research
Background:
- Erythrocyte complement receptor Type 1 (E-CR1) is crucial for clearing immune complexes (ICs) in primates.
- Chronic IC formation can lead to IC-mediated glomerulonephritis (IC-GN).
- Previous acute studies suggest increasing E-CR1 may offer protection against IC-GN.
Purpose of the Study:
- To test the hypothesis that chronically elevated E-CR1 levels protect against IC-GN.
- To investigate the therapeutic potential of modulating E-CR1 in IC-GN.
Main Methods:
- Immune complex glomerulonephritis (IC-GN) was induced in cynomolgus monkeys (CYN) via daily BGG infusions for 8-14 weeks.
- Sustained differences in E-CR1 levels were achieved using twice-weekly exchange transfusions with high/low E-CR1 expressing donors or weekly phlebotomy to stimulate erythropoiesis.
- Control groups received sham procedures or maintained/decreased E-CR1 levels.
Main Results:
- The study established methods to create sustained differences in E-CR1 levels in cynomolgus monkeys.
- The experimental groups demonstrated increased E-CR1 levels compared to controls.
- The abstract does not contain specific results on IC-GN development or protection.
Conclusions:
- The study successfully created experimental models with altered E-CR1 levels in cynomolgus monkeys.
- Further analysis is required to determine if elevated E-CR1 levels protect against IC-GN development.
- This research provides a foundation for investigating E-CR1 modulation as a therapeutic strategy for IC-GN.
Related Concept Videos
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...